Cargando…
Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
Monoclonal antibody-based targeted therapies have greatly improved treatment options for patients by binding to the innate immune system. However, the long-term efficacy of such antibodies is limited by mechanisms of drug resistance. Over the last 50 years, with advances in protein engineering techn...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543353/ https://www.ncbi.nlm.nih.gov/pubmed/37772505 http://dx.doi.org/10.1080/21645515.2023.2256904 |